Table 4.
Variable | Odds ratio | 95% CI |
---|---|---|
Gender | 1.616 | 0.721–3.727 |
Age | 1.106* | 1.018–1.203 |
Age at onset of PD | 0.837** | 0.766–0.910 |
Time from onset to initiation with levodopa | 0.746** | 0.624–0.870 |
Akinetic‐rigid subtype | 2.559* | 1.087–6.199 |
PIGD subtype | 1.024 | 0.379–3.188 |
LEDD | 1.003** | 1.001–1.004 |
MDS‐UPDRS II | 1.058 | 0.979–1.145 |
MDS‐UPDRS III | 0.998 | 0.969–1.027 |
BDI | 1.008 | 0.956–1.063 |
PDQ‐39 SI | 0.987 | 0.956–1.019 |
PD, Parkinson's disease; CI, confidence interval; PIGD, postural instability, and gait disorder; LEDD, levodopa equivalent daily dose; MDS‐UPDRS, the Movement Disorders Society's Unified Parkinson's Disease Rating Scale; BDI, the Beck Depression Inventory; PDQ‐39 SI, the Parkinson's Disease Questionnaire Summary Index.
**p < .001.
*p < .05.